Correlation Between Landos Biopharma and Decibel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Landos Biopharma and Decibel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Landos Biopharma and Decibel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Landos Biopharma and Decibel Therapeutics, you can compare the effects of market volatilities on Landos Biopharma and Decibel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Landos Biopharma with a short position of Decibel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Landos Biopharma and Decibel Therapeutics.
Diversification Opportunities for Landos Biopharma and Decibel Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Landos and Decibel is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Landos Biopharma and Decibel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Therapeutics and Landos Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Landos Biopharma are associated (or correlated) with Decibel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Therapeutics has no effect on the direction of Landos Biopharma i.e., Landos Biopharma and Decibel Therapeutics go up and down completely randomly.
Pair Corralation between Landos Biopharma and Decibel Therapeutics
If you would invest 308.00 in Decibel Therapeutics on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Decibel Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Landos Biopharma vs. Decibel Therapeutics
Performance |
| Timeline |
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Decibel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Landos Biopharma and Decibel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Landos Biopharma and Decibel Therapeutics
The main advantage of trading using opposite Landos Biopharma and Decibel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Landos Biopharma position performs unexpectedly, Decibel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Therapeutics will offset losses from the drop in Decibel Therapeutics' long position.| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
| Decibel Therapeutics vs. Werewolf Therapeutics | Decibel Therapeutics vs. Edgewise Therapeutics | Decibel Therapeutics vs. Celcuity LLC | Decibel Therapeutics vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |